Scientia Pharmaceutica

Scientia Pharmaceutica is an international, peer-reviewed, open access journal related to the pharmaceutical sciences. The journal is owned by the Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG) and is published quarterly online by MDPI and in print by the Austrian Pharmacists' Publishing House (Österreichischer Apothekerverlag). 
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), Embase, CAPlus / SciFinder, and other databases.
  • Journal Rank: CiteScore - Q2 (Pharmaceutical Science)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 17.4 days after submission; acceptance to publication is undertaken in 7.5 days (median values for papers published in this journal in the second half of 2022).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biomolecules, IJMS, Molecules, Sci. Pharm., Cancers, Marine Drugs
Antitumor Activity of Natural Products and Related Compounds Topic Editors: Barbara De Filippis, Alessandra Ammazzalorso, Marialuigia Fantacuzzi
Deadline: 31 August 2023
Topic in CIMB, IJMS, IJTM, Sci. Pharm.
Molecular Mechanism, Diagnosis and Treatment of Retinal and Optic Nerve Diseases Topic Editors: Stephanie C. Joachim, Bettina Hohberger, Julie Sanderson, Jan Darius Unterlauft, Lauren K. Wareham
Deadline: 31 October 2023
Topic in Biomedicines, JCM, Molecules, Pharmaceutics, Sci. Pharm., IJMS
Cannabis, Cannabinoids and Its Derivatives Topic Editors: Melanie Kelly, Christian Lehmann
Deadline: 30 September 2024
Topic in Biomedicines, Biomolecules, IJMS, Sci. Pharm., Plants, Foods, Molecules
Natural Products and Drug Discovery Topic Editors: Marta Menegazzi, Sonia Piacente
Deadline: 31 December 2024
Back to TopTop